1. Home
  2. RDHL vs AMST Comparison

RDHL vs AMST Comparison

Compare RDHL & AMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • AMST
  • Stock Information
  • Founded
  • RDHL 2009
  • AMST 2017
  • Country
  • RDHL Israel
  • AMST United States
  • Employees
  • RDHL N/A
  • AMST N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • AMST Computer Software: Prepackaged Software
  • Sector
  • RDHL Health Care
  • AMST Technology
  • Exchange
  • RDHL Nasdaq
  • AMST Nasdaq
  • Market Cap
  • RDHL 8.2M
  • AMST 7.4M
  • IPO Year
  • RDHL N/A
  • AMST 2020
  • Fundamental
  • Price
  • RDHL $5.85
  • AMST $3.29
  • Analyst Decision
  • RDHL
  • AMST
  • Analyst Count
  • RDHL 0
  • AMST 0
  • Target Price
  • RDHL N/A
  • AMST N/A
  • AVG Volume (30 Days)
  • RDHL 11.1K
  • AMST 93.6K
  • Earning Date
  • RDHL 08-29-2024
  • AMST 02-18-2025
  • Dividend Yield
  • RDHL N/A
  • AMST N/A
  • EPS Growth
  • RDHL N/A
  • AMST N/A
  • EPS
  • RDHL N/A
  • AMST N/A
  • Revenue
  • RDHL $3,707,000.00
  • AMST $86,115.00
  • Revenue This Year
  • RDHL $224.90
  • AMST N/A
  • Revenue Next Year
  • RDHL $82.69
  • AMST N/A
  • P/E Ratio
  • RDHL N/A
  • AMST N/A
  • Revenue Growth
  • RDHL N/A
  • AMST N/A
  • 52 Week Low
  • RDHL $5.41
  • AMST $1.85
  • 52 Week High
  • RDHL $20.28
  • AMST $6.27
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • AMST 44.21
  • Support Level
  • RDHL $5.80
  • AMST $3.15
  • Resistance Level
  • RDHL $6.26
  • AMST $3.74
  • Average True Range (ATR)
  • RDHL 0.31
  • AMST 0.21
  • MACD
  • RDHL 0.01
  • AMST -0.00
  • Stochastic Oscillator
  • RDHL 19.33
  • AMST 24.62

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

Share on Social Networks: